Rory F. Leisegang
Cape Town, WC, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Model-based somapacitan dosing and IGF-I response in children born SGA or with ISS, Noonan or Turner syndromes.
Journal: Journal of the Endocrine Society
Published: September 23, 2025
Contemporary study of acute myocarditis in South Africa: CAMISA.
Journal: Open heart
Published: July 14, 2024
Correction: Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy Volunteers.
Journal: Clinical pharmacokinetics
Published: May 02, 2024
Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg.
Journal: Journal of the International AIDS Society
Published: April 18, 2024
Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy Volunteers.
Journal: Clinical pharmacokinetics
Published: February 26, 2024
Immunogenicity dynamics and covariate effects after satralizumab administration predicted with a hidden Markov model.
Journal: CPT: pharmacometrics & systems pharmacology
Published: January 23, 2024
Novel Versus Conventional Sequencing of β-Blockers, Sodium/Glucose Cotransportor 2 Inhibitors, Angiotensin Receptor-Neprilysin Inhibitors, and Mineralocorticoid Receptor Antagonists in Stable Patients With Heart Failure With Reduced Ejection Fraction (NovCon Sequencing Study): Protocol for a Randomized Controlled Trial.
Journal: JMIR research protocols
Published: November 03, 2022
Access to novel anti-diabetic agents in resource limited settings: A brief commentary.
Journal: World journal of diabetes
Published: October 13, 2022
Optimal dosing of gliclazide-A model-based approach.
Journal: Basic & clinical pharmacology & toxicology
Published: October 04, 2022
Real-world evidence and product development: Opportunities, challenges and risk mitigation.
Journal: Wiener klinische Wochenschrift
Published: December 08, 2020
Last Updated: 09/26/2026